Luo‐Qi Zhou

8.0k total citations · 3 hit papers
41 papers, 5.3k citations indexed

About

Luo‐Qi Zhou is a scholar working on Neurology, Molecular Biology and Immunology. According to data from OpenAlex, Luo‐Qi Zhou has authored 41 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 14 papers in Molecular Biology and 13 papers in Immunology. Recurrent topics in Luo‐Qi Zhou's work include Neuroinflammation and Neurodegeneration Mechanisms (18 papers), Immune cells in cancer (7 papers) and Inflammation biomarkers and pathways (6 papers). Luo‐Qi Zhou is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (18 papers), Immune cells in cancer (7 papers) and Inflammation biomarkers and pathways (6 papers). Luo‐Qi Zhou collaborates with scholars based in China, United States and Germany. Luo‐Qi Zhou's co-authors include Dai‐Shi Tian, Chuan Qin, Sheng Yang, Ke Shang, Ziwei Hu, Shuoqi Zhang, Cuihong Xie, Ke Ma, Wei Wang and Tao Yu and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Brain.

In The Last Decade

Luo‐Qi Zhou

39 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

2020 3.4k citations Chuan Qin, Luo‐Qi Zhou et al. profile →
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China

2020 616 citations Chuan Qin, Luo‐Qi Zhou et al. profile →
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions

2022 521 citations Chuan Qin, Sheng Yang et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luo‐Qi Zhou China	18	3.4k	2.0k	781	761	660	41	5.3k
Chuan Qin China	30	3.8k 1.1×	2.4k 1.2×	1.5k 1.9×	1000 1.3×	1.1k 1.6×	112	7.9k
Xiong Wang China	29	3.5k 1.0×	1.9k 0.9×	1.3k 1.7×	1.2k 1.6×	300 0.5×	140	6.5k
Dai‐Shi Tian China	34	3.5k 1.0×	2.5k 1.2×	1.6k 2.0×	932 1.2×	1.3k 2.0×	114	8.2k
Inge Hamming Netherlands	14	3.5k 1.0×	1.7k 0.9×	721 0.9×	410 0.5×	315 0.5×	21	5.4k
G. Navis Netherlands	18	3.3k 1.0×	1.7k 0.8×	662 0.8×	405 0.5×	314 0.5×	35	5.7k
Zhibing Lu China	32	2.4k 0.7×	1.5k 0.7×	574 0.7×	651 0.9×	182 0.3×	139	5.7k
He Huang China	31	2.6k 0.8×	1.6k 0.8×	1.2k 1.6×	795 1.0×	333 0.5×	163	6.1k
Keiji Kuba Japan	29	2.3k 0.7×	845 0.4×	1.3k 1.6×	457 0.6×	487 0.7×	59	5.2k
Κassem Sharif Israel	27	1.4k 0.4×	855 0.4×	486 0.6×	324 0.4×	614 0.9×	101	3.7k
Enrico Ammirati Italy	34	1.7k 0.5×	961 0.5×	672 0.9×	486 0.6×	992 1.5×	153	6.3k

Countries citing papers authored by Luo‐Qi Zhou

Since Specialization

Citations

This map shows the geographic impact of Luo‐Qi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luo‐Qi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luo‐Qi Zhou more than expected).

Fields of papers citing papers by Luo‐Qi Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luo‐Qi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luo‐Qi Zhou. The network helps show where Luo‐Qi Zhou may publish in the future.

Co-authorship network of co-authors of Luo‐Qi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Luo‐Qi Zhou. A scholar is included among the top collaborators of Luo‐Qi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luo‐Qi Zhou. Luo‐Qi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pang, Xiao‐Wei, Lifang Zhu, Ming‐Hao Dong, et al.. (2025). Circulating insulin-like growth factor-1 and the risk of multiple sclerosis: a prospective cohort study. Multiple Sclerosis and Related Disorders. 94. 106281–106281.

Zhang, Lan, Xiao‐Wei Pang, Luo‐Qi Zhou, et al.. (2025). Gut Microbiota and White Matter Integrity: A Two-Sample Mendelian Randomization Analysis. eNeuro. 12(9). ENEURO.0586–24.2025.

Zhang, Hang, Luo‐Qi Zhou, Sheng Yang, et al.. (2025). The foam cell-derived exosomes exacerbate ischemic white matter injury via transmitting metabolic defects to microglia. Cell Metabolism. 37(8). 1636–1654.e10. 2 indexed citations

Zhu, Lifang, Luyang Zhang, Yun‐Hui Chu, et al.. (2024). Causal association between the peripheral immunity and the risk and disease severity of multiple sclerosis. Frontiers in Immunology. 15. 1325938–1325938. 1 indexed citations

Tian, Dai‐Shi, Chuan Qin, Ming‐Hao Dong, et al.. (2024). B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis. EMBO Molecular Medicine. 16(4). 966–987. 30 indexed citations

Qin, Chuan, Ming‐Hao Dong, Luo‐Qi Zhou, et al.. (2024). Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy. Proceedings of the National Academy of Sciences. 121(6). e2315990121–e2315990121. 42 indexed citations

You, Yun‐Fan, Ming‐Hao Dong, Xiao‐Wei Pang, et al.. (2024). Systematic Druggable Genome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Functional Outcome After Ischemic Stroke. Journal of the American Heart Association. 13(16). e034749–e034749. 2 indexed citations

Dong, Ming‐Hao, Xiao‐Wei Pang, Hang Zhang, et al.. (2024). Macrophage exosomal miR-30c-2-3p in atherosclerotic plaques aggravates microglial neuroinflammation during large-artery atherosclerotic stroke via TGF-β/SMAD2 pathway. Journal of Neuroinflammation. 21(1). 292–292. 9 indexed citations

Qin, Chuan, Dai‐Shi Tian, Luo‐Qi Zhou, & Wei Wang. (2023). Anti-BCMA CAR T-CELL therapy CT103A in relapsed or refractory AQP4-IGG seropositive neuromyelitis optica spectrum disorders: Phase 1 trial interim results. Journal of the Neurological Sciences. 455. 121220–121220. 2 indexed citations

10.

Qin, Chuan, Sheng Yang, Man Chen, et al.. (2023). Modulation of microglial metabolism facilitates regeneration in demyelination. iScience. 26(5). 106588–106588. 13 indexed citations

11.

Zhou, Luo‐Qi, et al.. (2023). Potential therapeutic targets for sarcopenia identified by Mendelian randomisation. Age and Ageing. 52(2). 16 indexed citations

12.

Qin, Chuanbo, Man Chen, Yun‐Hui Chu, et al.. (2023). TREM2‐IGF1 Mediated Glucometabolic Enhancement Underlies Microglial Neuroprotective Properties During Ischemic Stroke. Advanced Science. 11(10). e2305614–e2305614. 23 indexed citations

13.

Qin, Chuan, Dai‐Shi Tian, Luo‐Qi Zhou, et al.. (2023). Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results. Signal Transduction and Targeted Therapy. 8(1). 5–5. 93 indexed citations

14.

Xiao, Jun, Xin Chen, Yun‐Hui Chu, et al.. (2023). Naïve-memory regulatory T cells ratio is a prognostic biomarker for patients with acute ischemic stroke. Frontiers in Aging Neuroscience. 15. 1072980–1072980. 2 indexed citations

15.

Deng, Gang, Yun‐Hui Chu, Jun Xiao, et al.. (2023). Risk Factors, Pathophysiologic Mechanisms, and Potential Treatment Strategies of Futile Recanalization after Endovascular Therapy in Acute Ischemic Stroke. Aging and Disease. 14(6). 2096–2096. 41 indexed citations

16.

Tian, Dai‐Shi, Chuan Qin, Luo‐Qi Zhou, et al.. (2022). FSAP aggravated endothelial dysfunction and neurological deficits in acute ischemic stroke due to large vessel occlusion. Signal Transduction and Targeted Therapy. 7(1). 6–6. 31 indexed citations

17.

Dong, Ming‐Hao, Luo‐Qi Zhou, Man Chen, et al.. (2022). CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study. Journal of Neuroinflammation. 19(1). 79–79. 17 indexed citations

18.

Zhou, Xuan, et al.. (2021). Effects of vaginal microbiota and cervical cerclage on obstetric outcomes of twin pregnancies with cervical incompetence: a retrospective study. Archives of Gynecology and Obstetrics. 305(1). 77–86. 4 indexed citations

19.

Zhang, Shuoqi, Man Chen, Luo‐Qi Zhou, et al.. (2021). Sphingosine-1-Phosphate Signaling in Ischemic Stroke: From Bench to Bedside and Beyond. Frontiers in Cellular Neuroscience. 15. 781098–781098. 11 indexed citations

20.

Zhou, Luo‐Qi, Sheng Yang, Man Chen, et al.. (2020). FTY720 Modulates Microglia Toward Anti-inflammatory Phenotype by Suppressing Autophagy via STAT1 Pathway. Cellular and Molecular Neurobiology. 41(2). 353–364. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact